O. Klungel

First name
Middle name
Last name
Wing, K., Bhaskaran, K., Smeeth, L., van Staa, T. P., Klungel, O. H., Reynolds, R. F., & Douglas, I. (2016). Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury. BMJ Open. http://doi.org/10.1136/bmjopen-2016-012102
Requena, G., Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., et al. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816
Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., et al. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825
De Jong, H. J. I., van Staa, T. P., Lalmohamed, A., de Vries, F., Vandebriel, R. J., Van Loveren, H., et al. (2017). Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2016-210936
Wing, K., Bhaskaran, K., Pealing, L., Root, A., Smeeth, L., van Staa, T. P., et al. (2017). Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study. J Antimicrob Chemother. http://doi.org/10.1093/jac/dkx183
Ankarfeldt, M. Z., Thorsted, B. L., Groenwold, R. H., Adalsteinsson, E., Ali, M. S., & Klungel, O. H. (2017). Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study. Clin Epidemiol. http://doi.org/10.2147/clep.s124054
van Dalem, J., Brouwers, M., Stehouwer, C. D. A., Krings, A., Klungel, O. H., Driessen, J. H. M., et al. (2018). Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13168
De Jong, H. J. I., Tervaert, J. W. C., Lalmohamed, A., de Vries, F., Vandebriel, R. J., Van Loveren, H., et al. (2018). Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink. PLoS One. http://doi.org/10.1371/journal.pone.0193297
Althunian, T. A., de Boer, A., Groenwold, R. H. H., Rengerink, K. O., Souverein, P. C., & Klungel, O. H. (2020). Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5065
van Dalem, J., Driessen, J. H. M., Burden, A. M., Stehouwer, C. D. A., Klungel, O. H., de Vries, F., & Brouwers, M. (2021). Thiazolidinediones and Glucagon-like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study. Hepatology. http://doi.org/10.1002/hep.32012